Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

10 results about "Serine protease activity" patented technology

A method for preparing protein polypeptide using bullwhip and its application

ActiveCN118652953BHas the effect of regulating kidney yang deficiency syndromeLess fat residueHydrolysed protein ingredientsPeptide preparation methodsBovine collagenHypothalamus
The invention belongs to the technical field of cowhide collagen polypeptide products, and specifically relates to a method for preparing protein polypeptides from bullwhips and an application thereof. The preparation method comprises primary processing of raw materials, secondary processing of raw materials, fat homogenization, enzymolysis, separation and filtration, concentration and drying. The protease selected in the method is serine protease, the active concentration of serine protease is 3000U / g, the enzymolysis time is 2.5h, the yield of bullwhip protein polypeptide obtained by the enzymolysis is high, and the method is suitable for large-scale application, and the production efficiency is effectively improved, and the cost of waste treatment and the like is reduced. The bullwhip raw material selected in the method is the bullwhip of a specific pedigree Simmental cattle. Compared with bullwhip raw materials of other pedigrees, the bullwhip protein polypeptide prepared from the bullwhip of the Simmental cattle has the effect of resisting oxidative stress of the reproductive system, and the improvement effect of the bullwhip protein polypeptide on renal function and hypothalamus-pituitary-adrenal axis function proves that the bullwhip protein polypeptide has the effect of regulating and controlling kidney yang deficiency syndrome.
Owner:CHANGCHUN XINMU TECH CO LTD

Serine protease selectively degrading mucin and uses thereof

The present application relates to a serine protease that selectively degrades mucin and uses thereof. The serine protease is serine protease EatA, and the protein contains a passenger domain with serine protease EatA activity, and the amino acid sequence of the passenger domain is at least 90% identical to SEQ ID NO: 2, preferably the amino acid sequence shown in SEQ ID NO: 2. The serine protease EatA can selectively degrade mucin in disease-related mucus and is highly stable over a long period of time.
Owner:孙正龙

A coral-derived procoagulant polypeptide and uses thereof

PendingCN122277711ALiver hemorrhageCerebral hemorrhages
This invention belongs to the field of biomedicine and relates to a procoagulant polypeptide TPTX and its applications. The procoagulant polypeptide TPTX of this invention can exert its procoagulant and hemostatic effects by specifically inhibiting plasmin activity. Experiments have shown that TPTX exhibits significant dose-dependent procoagulant and hemostatic effects in ferric chloride-induced mouse carotid artery thrombosis models, mouse liver hemorrhage models, mouse tail hemorrhage models, and mouse saphenous vein hemorrhage models, with effects superior to the positive control drug 6-aminocaproic acid. Simultaneously, TPTX can reduce the area of ​​atorvastatin-induced cerebral hemorrhage in zebrafish and improve their motor dysfunction. Mechanistic studies show that TPTX has an inhibitory constant Ki of 17.76 nM on plasmin and has no significant effect on the activity of seven other key serine proteases in the coagulation system, demonstrating a clear target and high selectivity. The procoagulant polypeptide of this invention can be used to prepare hemostatic drugs, possessing the advantages of high efficiency, clear target, and high selectivity, with broad prospects for clinical application.
Owner:GUANGXI UNIV OF CHINESE MEDICINE

Methods of preparing albumin preparations

Described are human serum albumin (hSA) preparations prepared from human plasma and methods of preparing them. The preparations have an amount of C1 esterase (C1E) inhibitor activity and exhibit stability against serine protease activity.
Owner:CENTEON LLC

Improvement of down-regulation of histone cytotoxicity by a complex of a negatively charged polysaccharide and a protease

The present disclosure describes a complex of a negatively charged polysaccharide and a protein having serine protease activity. The negatively charged polypeptide is, for example, heparin or non-anticoagulant heparin. The serine protease is, for example, elastase or activated protein C. The complex can be used for the treatment, prevention or amelioration of diseases or disorders associated with immunothrombosis.
Owner:MAASTRICHT UNIVERSITY +1

Fusion proteins, recombinant bacteria, and exosporium fragments for pest control and plant health

ActiveUS12527323B2BiocideBacteriaBiotechnologySerine protease activity
The present invention relates to a fusion protein having a targeting sequence, exosporium protein, or exosporium protein fragment that targets the fusion protein to the exosporium of a recombinant Bacillus cereus family member and an enzyme having serine protease activity, wherein the enzyme having serine protease activity is from Bacillus firmus or is a variant of such enzyme. The present invention also provides a recombinant Bacillus cereus family member that expresses such fusion protein and exosporium fragments derived from such recombinant Bacillus cereus family member. Methods of using such recombinant Bacillus cereus family members or exosporium fragments derived therefrom for nematode control are also provided.
Owner:BAYER CROPSCIENCE LLC

Polypeptides having serine protease activity and polynucleotides encoding them and their use in animal feed

The present invention relates to animal feed or animal feed additive comprising a polypeptide having protease activity and uses thereof. Specifically, the protease is a serine S1 protease from the genera Microspora, Terracoccus and Knoellia, all belonging to the family Microbacteriaceae of the suborder Micrococineae. These proteases have high activity over a broad pH range (pH 3-7) and are thus highly active during the entire passage through the digestive tract. It further relates to methods for producing these proteases as well as using the proteases to improve animal performance and the nutritional value of animal feed.
Owner:NOVOZYMES AS

Influenza virus sensitization cell strain and construction method and application thereof

The invention belongs to the technical field of biology, and discloses an influenza virus sensitizing cell strain as well as a construction method and application thereof. The influenza virus sensibilization cell strain STX-TMP2 can stably express a human-derived influenza virus receptor ST6GAL1 and utilizes doxycycline to controllably induce a TMPRSS2 protein. The invention also discloses a preparation method of the influenza virus sensibilization cell strain STX-TMP2. The preservation number of the cell strain STX-TMP2 is GDMCC (China General Microbiological Culture Collection Center) NO: 67099; the cell strain has the following advantages: low toxicity: low background expression is realized through a Tet-on system, cytotoxicity caused by continuous high expression is significantly reduced, and long-term stable passage of the cell strain is ensured; controllability: the doxycycline can regulate and control the expression level and flexibly adapt to the production requirements of influenza virus vaccine strains; high efficiency: in an induction state, the cells have enough receptor expression and serine protease activity at the same time, and the amplification efficiency of the codon reprogramming virus with relatively low replication capacity is remarkably improved; wide applicability: the method is not only suitable for production of influenza virus vaccine strains with codon reprogramming, but also can be popularized to various production systems of attenuated influenza vaccines with relatively low replication ability.
Owner:THE FIRST AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL UNIV (GUANGZHOU RESPIRATORY CENT) +3

Protease enzyme variants and uses thereof

The present invention is related to variants of fungal serine protease enzyme, which have serine protease activity of Malbranchea protease. Also disclosed are isolated nucleic acid molecules, comprising polynucleotide sequences which encode variants of fungal serine protease enzyme, nucleic acid sequences encoding said protease variants, a host cell and a process of producing polypeptides having serine protease activity. Said protease variants are useful as enzyme preparations applicable in detergent compositions and for treating fibers, wool, hair, leather, or silk, for treating food or feed, or for any applications involving modification, degradation or removal of proteinaceous material.
Owner:AB ENZYMES OY